| Literature DB >> 31874730 |
Taichi Matsubara1, Hiroshi Uchi2, Naoki Haratake1, Shinkichi Takamori1, Ryo Toyozawa1, Naoko Miura1, Masafumi Yamaguchi1, Takashi Seto1, Mitsuhiro Takenoyama3.
Abstract
Entities:
Keywords: AGEP; Adverse event; Cutaneous disorder; Immune checkpoint inhibitor; lung cancer
Mesh:
Substances:
Year: 2019 PMID: 31874730 DOI: 10.1016/j.cllc.2019.11.009
Source DB: PubMed Journal: Clin Lung Cancer ISSN: 1525-7304 Impact factor: 4.785